Tag: CX 2021

trerotola misra tan av access dcbs drug coated balloons

More mixed results for DCBs in AV access maintenance as evidence...

Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...

Vascular News’ top 10 most popular stories of April 2021

Highlights from the Charing Cross (CX) 2021 Digital Edition (19–22 April, online)—including the potential of Philips’ Fiber Optic RealShape (FORS) technology to reduce radiation...
Medtronic IN.PACT AV

Two-year IN.PACT AV Access results presented at CX 2021

Medtronic recently announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually...

CX 2021 poll sees thrombolysis trump endovascular treatment in basilar artery...

A series of debates tested expert response to current acute stroke controversies during the final day of the Charing Cross (CX) 2021 Digital Edition...

Vascular surgeons integral to critical bleeding trauma cases, 77% of CX...

Vascular surgeons have an integral role to play in major haemorrhage protocol (MHP) trauma calls, polling taken during the Vascular Trauma Controversies session at...

CX audience demands urgent action on quicker diagnosis of hurting legs

There is a global crisis, also playing out in developed Western countries, in which too many people are having unnecessary amputations, so losing their...
ePTFE

Real data and experience for below-the-knee bypass back heparin-bonded ePTFE as...

In a Gore-sponsored satellite symposium at the 2021 Charing Cross (CX) Digital Edition (19–22 April, online), Richard Neville (Falls Church, USA) and Walter Dorigo...

CX 2021: Underlying thoracic aortic pathology is key and patients deserve...

The message that outcomes depend on the underlying pathology was front and centre during the Thoracic Aortic Controversies discussion at the Charing Cross (CX)...

Debate over flow reduction in asymptomatic high-flow fistulas leaves CX 2021...

Consensus is split over the need for flow reduction in high-flow fistulas to avoid cardiac complications in dialysis patients, polling taken during the Charing...

CX audience supports call to change agency recommendations regarding paclitaxel use...

Addressing representatives from the US Food and Drug Administration (FDA) and UK Medicines and Healthcare products Regulatory Agency (MHRA) directly, Thomas Zeller (Bad Krozingen,...
Viabahn

Viabahn balloon-expandable stent can successfully treat occlusive Iliac artery pathology, CX...

In a Gore-sponsored Satellite Symposium at the Charing Cross Symposium (CX; 19–22 April, online), Michele Piazza (Padua, Italy) moderated a discussion on occlusive Iliac...

“Radiation will be a thing of the past”: FORS in the...

Opening the Charing Cross (CX) 2021 Digital Edition (19–22 April, online), experts deliberated crucial controversies in the abdominal aortic space. Discussion emphasised the potential...
antimicrobial

Antimicrobial InterGard Synergy graft can be used in aortic infections when...

“In native or stentgraft aortic infections, when a biological solution is not feasible, the antimicrobial Synergy graft (Getinge) offers an alternative solution with a...

BUTTERFLY study finds most reinterventions after FEVAR are not related to...

A mid-term assessment of bridging stentgraft integrity and flare geometry following fenestrated endovascular aortic repair (FEVAR) finds that, although there is a substantial reintervention...

CX 2021: Controversies around “more and more complex procedures” will take...

“We are going to be seeing more and more complex procedures in the aortic arch and thoracoabdominal aorta”, Gustavo Oderich (University of Texas Health...

CX to highlight impact of high-flow arteriovenous fistulas in Vascular Access...

Nicholas Inston (Queen Elizabeth Hospital Birmingham, Birmingham, UK) speaks to Vascular News ahead of this year’s Charing Cross Symposium (CX), which is being held online 19–22 April. In...
paclitaxel

CX to host “vital” global discussion of paclitaxel controversy

Andrew Holden (Auckland City Hospital; University of Auckland, Auckland, New Zealand) speaks to Vascular News ahead of this year’s Charing Cross Symposium (CX), which...